These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 24511546

  • 1. Oncogenic PIK3CA mutation and dysregulation in human salivary duct carcinoma.
    Qiu W, Tong GX, Turk AT, Close LG, Caruana SM, Su GH.
    Biomed Res Int; 2014; 2014():810487. PubMed ID: 24511546
    [Abstract] [Full Text] [Related]

  • 2. PIK3CA mutations and PTEN loss in salivary duct carcinomas.
    Griffith CC, Seethala RR, Luvison A, Miller M, Chiosea SI.
    Am J Surg Pathol; 2013 Aug; 37(8):1201-7. PubMed ID: 23851329
    [Abstract] [Full Text] [Related]

  • 3. Novel mutant-enriched sequencing identified high frequency of PIK3CA mutations in pharyngeal cancer.
    Qiu W, Tong GX, Manolidis S, Close LG, Assaad AM, Su GH.
    Int J Cancer; 2008 Mar 01; 122(5):1189-94. PubMed ID: 17990317
    [Abstract] [Full Text] [Related]

  • 4. PIK3CA mutations in head and neck squamous cell carcinoma.
    Qiu W, Schönleben F, Li X, Ho DJ, Close LG, Manolidis S, Bennett BP, Su GH.
    Clin Cancer Res; 2006 Mar 01; 12(5):1441-6. PubMed ID: 16533766
    [Abstract] [Full Text] [Related]

  • 5. Frequent PTEN loss and differential HER2/PI3K signaling pathway alterations in salivary duct carcinoma: Implications for targeted therapy.
    Saintigny P, Mitani Y, Pytynia KB, Ferrarotto R, Roberts DB, Weber RS, Kies MS, Maity SN, Lin SH, El-Naggar AK.
    Cancer; 2018 Sep 15; 124(18):3693-3705. PubMed ID: 30289966
    [Abstract] [Full Text] [Related]

  • 6. Molecular characterization of apocrine salivary duct carcinoma.
    Chiosea SI, Williams L, Griffith CC, Thompson LD, Weinreb I, Bauman JE, Luvison A, Roy S, Seethala RR, Nikiforova MN.
    Am J Surg Pathol; 2015 Jun 15; 39(6):744-52. PubMed ID: 25723113
    [Abstract] [Full Text] [Related]

  • 7. Response of head and neck squamous cell carcinoma cells carrying PIK3CA mutations to selected targeted therapies.
    Wirtz ED, Hoshino D, Maldonado AT, Tyson DR, Weaver AM.
    JAMA Otolaryngol Head Neck Surg; 2015 Jun 15; 141(6):543-9. PubMed ID: 25855885
    [Abstract] [Full Text] [Related]

  • 8. Are acinic cell carcinomas of the breast and salivary glands distinct diseases?
    Piscuoglio S, Hodi Z, Katabi N, Guerini-Rocco E, Macedo GS, Ng CK, Edelweiss M, De Mattos-Arruda L, Wen HY, Rakha EA, Ellis IO, Rubin BP, Weigelt B, Reis-Filho JS.
    Histopathology; 2015 Oct 15; 67(4):529-37. PubMed ID: 25688711
    [Abstract] [Full Text] [Related]

  • 9. Mutational analysis of PI3K/AKT and RAS/RAF pathway activation in malignant salivary gland tumours with a new mutation of PIK3CA.
    Shalmon B, Drendel M, Wolf M, Hirshberg A, Cohen Y.
    Int J Oral Maxillofac Surg; 2016 Jun 15; 45(6):721-5. PubMed ID: 26811072
    [Abstract] [Full Text] [Related]

  • 10. Sclerosing Polycystic "Adenosis" of Salivary Glands: A Neoplasm Characterized by PI3K Pathway Alterations More Correctly Named Sclerosing Polycystic Adenoma.
    Bishop JA, Gagan J, Baumhoer D, McLean-Holden AL, Oliai BR, Couce M, Thompson LDR.
    Head Neck Pathol; 2020 Sep 15; 14(3):630-636. PubMed ID: 31605313
    [Abstract] [Full Text] [Related]

  • 11. Adenomyoepitheliomas of the Breast Frequently Harbor Recurrent Hotspot Mutations in PIK3-AKT Pathway-related Genes and a Subset Show Genetic Similarity to Salivary Gland Epithelial-Myoepithelial Carcinoma.
    Lubin D, Toorens E, Zhang PJ, Jaffer S, Baraban E, Bleiweiss IJ, Nayak A.
    Am J Surg Pathol; 2019 Jul 15; 43(7):1005-1013. PubMed ID: 31094929
    [Abstract] [Full Text] [Related]

  • 12. Detection of novel actionable genetic changes in salivary duct carcinoma helps direct patient treatment.
    Nardi V, Sadow PM, Juric D, Zhao D, Cosper AK, Bergethon K, Scialabba VL, Batten JM, Borger DR, Iafrate AJ, Heist RS, Lawrence DP, Flaherty KT, Bendell JC, Deschler D, Li Y, Wirth LJ, Dias-Santagata D.
    Clin Cancer Res; 2013 Jan 15; 19(2):480-90. PubMed ID: 23186780
    [Abstract] [Full Text] [Related]

  • 13. PI3K oncogenic mutations mediate resistance to afatinib in HER2/neu overexpressing gynecological cancers.
    Bonazzoli E, Cocco E, Lopez S, Bellone S, Zammataro L, Bianchi A, Manzano A, Yadav G, Manara P, Perrone E, Haines K, Espinal M, Dugan K, Menderes G, Altwerger G, Han C, Zeybek B, Litkouhi B, Ratner E, Silasi DA, Huang GS, Azodi M, Schwartz PE, Santin AD.
    Gynecol Oncol; 2019 Apr 15; 153(1):158-164. PubMed ID: 30630630
    [Abstract] [Full Text] [Related]

  • 14. Novel mutations of PIK3CA gene in head and neck squamous cell carcinoma.
    Al-Amri AM, Vatte C, Cyrus C, Chathoth S, Hashim TM, Mohamed YS, Al Ali R, Alsaid A, Al Ali A.
    Cancer Biomark; 2016 Apr 15; 16(3):377-83. PubMed ID: 26889984
    [Abstract] [Full Text] [Related]

  • 15. Novel therapeutic targets in salivary duct carcinoma uncovered by comprehensive molecular profiling.
    Gargano SM, Senarathne W, Feldman R, Florento E, Stafford P, Swensen J, Vranic S, Gatalica Z.
    Cancer Med; 2019 Dec 15; 8(17):7322-7329. PubMed ID: 31609094
    [Abstract] [Full Text] [Related]

  • 16. Detection of PIK3CA gene mutations with HRM analysis and association with IGFBP-5 expression levels in breast cancer.
    Dirican E, Kaya Z, Gullu G, Peker I, Ozmen T, Gulluoglu BM, Kaya H, Ozer A, Akkiprik M.
    Asian Pac J Cancer Prev; 2014 Dec 15; 15(21):9327-33. PubMed ID: 25422220
    [Abstract] [Full Text] [Related]

  • 17. The analysis of PIK3CA mutations in gastric carcinoma and metanalysis of literature suggest that exon-selectivity is a signature of cancer type.
    Barbi S, Cataldo I, De Manzoni G, Bersani S, Lamba S, Mattuzzi S, Bardelli A, Scarpa A.
    J Exp Clin Cancer Res; 2010 Apr 16; 29(1):32. PubMed ID: 20398348
    [Abstract] [Full Text] [Related]

  • 18. Clinicopathological study of intraductal carcinoma of the salivary gland, with emphasis on the apocrine type.
    Hsieh MS, Lee YH, Jin YT, Kuo YJ.
    Virchows Arch; 2020 Oct 16; 477(4):581-592. PubMed ID: 32383006
    [Abstract] [Full Text] [Related]

  • 19. Comprehensive Molecular Characterization of Salivary Duct Carcinoma Reveals Actionable Targets and Similarity to Apocrine Breast Cancer.
    Dalin MG, Desrichard A, Katabi N, Makarov V, Walsh LA, Lee KW, Wang Q, Armenia J, West L, Dogan S, Wang L, Ramaswami D, Ho AL, Ganly I, Solit DB, Berger MF, Schultz ND, Reis-Filho JS, Chan TA, Morris LG.
    Clin Cancer Res; 2016 Sep 15; 22(18):4623-33. PubMed ID: 27103403
    [Abstract] [Full Text] [Related]

  • 20. Biomarker immunoprofile and molecular characteristics in salivary duct carcinoma: clinicopathological and prognostic implications.
    Santana T, Pavel A, Martinek P, Steiner P, Grossmann P, Baněčková M, Skálová A.
    Hum Pathol; 2019 Nov 15; 93():37-47. PubMed ID: 31437521
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.